mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma

por Scheller, T, Hellerbrand, C, Moser, C, Schmidt, K, Kroemer, A, Brunner, S M, Schlitt, H J, Geissler, E K, Lang, S A
Publicado 2015